Walvax BioTech Asset Resilience Ratio

Latest as of June 2025: 2.20%

Walvax BioTech asset resilience ratio. Walvax BioTech (300142) has an Asset Resilience Ratio of 2.20% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Walvax BioTech (300142) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥308.17 Million

≈ $45.09 Million USD Cash + Short-term Investments

Total Assets

CN¥14.00 Billion

≈ $2.05 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Walvax BioTech (2013–2022)

Asset resilience ratio of Walvax BioTech from 2013 to 2022. This chart shows how Walvax BioTech's Asset Resilience Ratio has changed over time. Read how much debt does Walvax BioTech carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Walvax BioTech's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Walvax BioTech total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥308.17 Million	2.2%
Total Liquid Assets	CN¥308.17 Million	2.20%

Asset Resilience Insights

Limited Liquidity: Walvax BioTech maintains only 2.20% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Walvax BioTech Industry Peers by Asset Resilience Ratio

Compare Walvax BioTech's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Galderma Group N SW:GALD	Drug Manufacturers - Specialty & Generic	3.56%
Enzymatica publ AB ST:ENZY	Drug Manufacturers - Specialty & Generic	22.17%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	9.04%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%

Walvax BioTech Asset Resilience Ratio by Year (2013–2022)

Walvax BioTech asset resilience ratio by year from 2013 to 2022. The table below shows the annual Asset Resilience Ratio data for Walvax BioTech.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	-0.25%	CN¥-38.16 Million ≈ $-5.58 Million	CN¥15.34 Billion ≈ $2.24 Billion	+0.08pp
2021-12-31	-0.33%	CN¥-45.05 Million ≈ $-6.59 Million	CN¥13.67 Billion ≈ $2.00 Billion	+0.17pp
2020-12-31	-0.50%	CN¥-48.19 Million ≈ $-7.05 Million	CN¥9.65 Billion ≈ $1.41 Billion	+0.18pp
2019-12-31	-0.68%	CN¥-47.52 Million ≈ $-6.95 Million	CN¥7.02 Billion ≈ $1.03 Billion	-0.12pp
2018-12-31	-0.56%	CN¥-40.24 Million ≈ $-5.89 Million	CN¥7.24 Billion ≈ $1.06 Billion	+0.29pp
2017-12-31	-0.84%	CN¥-49.59 Million ≈ $-7.26 Million	CN¥5.88 Billion ≈ $859.84 Million	+0.13pp
2016-12-31	-0.98%	CN¥-61.90 Million ≈ $-9.06 Million	CN¥6.32 Billion ≈ $925.40 Million	-1.43pp
2015-12-31	0.45%	CN¥28.10 Million ≈ $4.11 Million	CN¥6.26 Billion ≈ $915.72 Million	+0.54pp
2013-12-31	-0.09%	CN¥-5.60 Million ≈ $-819.25K	CN¥6.14 Billion ≈ $897.87 Million	--

pp = percentage points

About Walvax BioTech

SHE:300142 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.55 Billion

CN¥17.42 Billion CNY

Market Cap Rank

#5185 Global

#825 in China

Share Price

CN¥10.89

Change (1 day)

-5.39%

52-Week Range

CN¥10.89 - CN¥16.10

All Time High

CN¥93.63